[1]聂优华,刘育斌.孟鲁司特联合普米克令舒吸入剂治疗小儿哮喘的疗效及对患儿炎性因子的影响[J].医学信息,2022,35(20):130-132.[doi:10.3969/j.issn.1006-1959.2022.20.035]
　NIE You-hua,LIU Yu-bin.Effect of of Montelukast Combined with Pulmicort Respules Inhalation in Treatment of Pediatric Asthma and its Influence on Inflammatory Factors[J].Journal of Medical Information,2022,35(20):130-132.[doi:10.3969/j.issn.1006-1959.2022.20.035]
点击复制

孟鲁司特联合普米克令舒吸入剂治疗小儿哮喘的疗效及对患儿炎性因子的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年20期
页码:
130-132
栏目:
药物与临床
出版日期:
2022-10-15

文章信息/Info

Title:
Effect of of Montelukast Combined with Pulmicort Respules Inhalation in Treatment of Pediatric Asthma and its Influence on Inflammatory Factors
文章编号:
1006-1959（2022）20-0130-03
作者:
聂优华; 刘育斌
（上高县人民医院小儿内科，江西 上高 336400）
Author(s):
NIE You-hua; LIU Yu-bin
(Department of Pediatrics,Shanggao County People’s Hospital,Shanggao 336400,Jiangxi,China)
关键词:
小儿哮喘; 孟鲁司特; 普米克令舒; 肺功能; 免疫功能; 炎性因子
Keywords:
Pediatric asthma; Montelukast; Pulmicort respules; Lung function; Immune function; Inflammatory cytokines
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2022.20.035
文献标志码:
A
摘要:
目的 探讨孟鲁司特与普米克令舒吸入剂联合治疗小儿哮喘的临床疗效及其对炎性因子的影响。方法 选取上高县人民医院2019年1月-2021年1月收治的哮喘小儿66例，采用随机数字表法分为对照组与联合治疗组，各33例。对照组予以普米克令舒吸入剂治疗，联合治疗组予以普米克令舒吸入剂联合孟鲁司特治疗。比较两组临床疗效、肺功能[第1 s用力呼气容积（FEV1）与用力肺活量（FVC）百分比（FEV1/FVC）、最大呼气流速（PEF）]、免疫功能（CD3+细胞分数、CD4+细胞分数、CD4+/CD8+比值）、血清炎性因子水平[肿瘤坏死因子α（TNF-α）、白细胞介素6（IL-6）、白细胞介素8（IL-8）及白细胞介素17（IL-17）]及日间与夜间症状评分。结果 联合治疗组临床疗效优于对照组，差异有统计学意义（P＜0.05）；联合治疗组FVC、FEV1、FEV1/FVC以及PEF水平均高于对照组，差异有统计学意义（P＜0.05）；联合治疗组TNF-α、IL-6、IL-8、IL-17水平及日间、夜间症状评分均低于对照组，差异有统计学意义（P＜0.05）。结论 孟鲁司特与普米克令舒吸入剂联合治疗小儿哮喘的临床疗效确切，能有效改善患儿哮喘症状、肺功能，降低炎性因子水平，值得临床应用。
Abstract:
Objective To investigate the clinical efficacy of montelukast combined with pulmicort respules inhalation in the treatment of pediatric asthma and its effect on inflammatory factors.Methods A total of 66 children with asthma admitted to Shanggao County People’s Hospital from January 2019 to January 2021 were selected and divided into a control group and a combined treatment group according to the random number table method, with 33 cases in each group. The control group was treated with pulmicort inhalation, and the combined treatment group was treated with pulmicort inhalation combined with montelukast. The clinical efficacy, pulmonary function [percentage of forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) (FEV1/FVC), peak expiratory flow rate (PEF)], immune function (CD3+ cell fraction, CD4+ cell fraction, CD4+/CD8+ ratio), serum inflammatory factor levels [tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-17 (IL-17)] and daytime and nighttime symptom scores were compared between the two groups.Results The clinical efficacy of the combined treatment group was better than that of the control group, and the difference was statistically significant (P<0.05). The levels of FVC, FEV1, FEV1/FVC and PEF in the combined treatment group were higher than those in the control group, and the differences were statistically significant (P<0.05). The levels of TNF-α, IL-6, IL-8, IL-17 and daytime and nighttime symptom scores in the combined treatment group were lower than those in the control group, and the differences were statistically significant (P<0.05).Conclusion The clinical efficacy of montelukast combined with pulmicort respules inhalation in the treatment of children with asthma is definite, which can effectively improve the asthma symptoms and lung function of children, reduce the level of inflammatory factors, and is worthy of clinical application.

参考文献/References:

[1]Bragina EY,Tiys ES,Freidin MB,et al.Insights into pathophysiology of dystrophy through the analysis of gene networks: an example of bronchial asthma and tuberculosis [J].Immunogenetics,2014,66(7/8):457-465.[2]Pernell BM,De Baun MR,Becker K,et al.Improving Medication Adherence with Two-way Short Message Service Reminders in Sickle Cell Disease and Asthma.A feasibility randomized controlled trial [J].Appl Clin Inform,2017,8(2):541-559.[3]胡玉菲,刘峰,柳俊芳.孟鲁司特联合布地奈德治疗支气管哮喘急性发作期患儿的效果及对免疫和肺功能的影响[J].解放军医药杂志,2020,32(6):51-55.[4]叶国秀,周宝琴,李艳鹏.氧驱雾化吸入普米克令舒治疗小儿哮喘急性发作的临床疗效及其对肺功能的影响[J].临床合理用药杂志,2021,14(3):12-13,16.[5]舒毅芳,牛小玲,吴杰.布地奈德雾化吸入联合“冬病夏治”中药穴位贴敷法治疗儿童哮喘的临床效果分析[J].实用临床医药杂志,2017,21(19):80-83.[6]李远西.普米克令舒雾化联合孟鲁司特钠治疗对支气管哮喘患儿肺功能及炎症状态的影响[J].西北国防医学杂志,2017,38(2):121-124.[7]乔喜娟.孟鲁司特钠联合氟替卡松气雾剂用于临床治疗小儿咳嗽变异性哮喘的效果[J].中国药物与临床,2021,21(10):1729-1731.[8]郭芳芳.孟鲁司特钠治疗中重度支气管哮喘的疗效及其对炎性因子与肺功能的影响[J].实用医药杂志,2021,38(7):605-608.[9]闫永彬,贾长虹,杨明江.从伏风暗瘀宿痰辨治小儿哮喘[J].中医杂志,2016,57(21):1877-1878,1881.[10]胡蓉,潘云波,王彦平.孟鲁司特在小儿支气管哮喘中的临床应用价值研究[J].川北医学院学报,2017,32(6):883-885.[11]宋颖,张胜红.观察舌下免疫治疗阻断学龄前儿童过敏性咳嗽变异型哮喘发展为典型哮喘的作用[J].中国免疫学杂志,2021,37(5):600-604,609.[12]李增清,邹有群,陈永新.甲基强的松龙和布地奈德在小儿哮喘中的应用[J].中华全科医学,2013,11(7):1030-1031.[13]熊必丹,喻晓,石克华.咳喘散穴位敷贴联合喘可治穴位注射治疗支气管哮喘临床研究[J].国际中医中药杂志,2020,42(7):644-647.[14]Ye YM,Kim SH,Hur GY,et al.Addition of Montelikast to Low Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy[J].Allergy Asthma Imminolres,2015,7(5):440-448.[15]施雪梅.普米克令舒治疗小儿哮喘急性发作的疗效及对肺功能的影响[J].中西医结合心血管病电子杂志,2020,8(35):37.

相似文献/References:

[1]尹静华.孟鲁司特钠治疗小儿哮喘的临床有效性分析[J].医学信息,2018,31(09):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
　YIN Jing-hua.Clinical Efficacy of Montelukast Sodium in Children with Asthma[J].Journal of Medical Information,2018,31(20):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
[2]刘玉振.孟鲁司特治疗支气管哮喘的临床研究[J].医学信息,2018,31(10):140.[doi:10.3969/j.issn.1006-1959.2018.10.047]
　LIU Yu-zhen.Clinical Study of Montelukast in the Treatment of Bronchial Asthma[J].Journal of Medical Information,2018,31(20):140.[doi:10.3969/j.issn.1006-1959.2018.10.047]
[3]张明荣.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床疗效分析[J].医学信息,2018,31(13):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
　ZHANG Ming-rong.Clinical Analysis of Montelukast Sodium Combined with Budesonide in the Treatment of Childhood Asthma[J].Journal of Medical Information,2018,31(20):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
[4]王 瑜.布地奈德混悬液联合特布他林治疗小儿哮喘的效果[J].医学信息,2022,35(12):184.[doi:10.3969/j.issn.1006-1959.2022.12.047]
　WANG Yu.Effect of Budesonide Suspension Combined with Terbutaline in the Treatment of Pediatric Asthma[J].Journal of Medical Information,2022,35(20):184.[doi:10.3969/j.issn.1006-1959.2022.12.047]
[5]张 斌,刘宿慧,余长寿.孟鲁司特联合噻托溴铵对COPD患者血清细胞因子、血液流变学及肺功能的影响[J].医学信息,2020,33(02):144.[doi:10.3969/j.issn.1006-1959.2020.02.043]
　ZHANG Bin,LIU Su-hui,YU Chang-shou.Effect of Montelukast Combined with Tiotropium Bromide on Serum Cytokines,Hemorheology and Lung Function in Patients with COPD[J].Journal of Medical Information,2020,33(20):144.[doi:10.3969/j.issn.1006-1959.2020.02.043]
[6]曾穗茹,王蓉梅.孟鲁司特联合布地奈德雾化吸入用于肺炎支原体感染后慢性咳嗽患儿的效果观察[J].医学信息,2018,31(19):137.[doi:10.3969/j.issn.1006-1959.2018.19.041]
　ZENG Sui-ru,WANG Rong-mei.Efficacy of Montelukast Combined with Budesonide Aerosol Inhalation in Children with Chronic Cough after Mycoplasma Pneumoniae Infection[J].Journal of Medical Information,2018,31(20):137.[doi:10.3969/j.issn.1006-1959.2018.19.041]
[7]杨一民,黄小玲,李 溦,等.LTA4H基因多态性对汉族儿童支气管哮喘患者使用孟鲁司特钠疗效及肺功能的影响[J].医学信息,2022,35(20):49.[doi:10.3969/j.issn.1006-1959.2022.20.011]
　YANG Yi-min,HUANG Xiao-ling,LI Wei,et al.Effect of LTA4H Gene Polymorphism on the Efficacy and Lung Function of Montelukast Sodium in Chinese Han Children with Bronchial Asthma[J].Journal of Medical Information,2022,35(20):49.[doi:10.3969/j.issn.1006-1959.2022.20.011]
[8]周冬娟.布地奈德联合西替利嗪治疗小儿哮喘对患儿呼吸功能及免疫功能指标的影响[J].医学信息,2022,35(03):103.[doi:10.3969/j.issn.1006-1959.2022.03.024]
　ZHOU Dong-juan.Effects of Budesonide Combined with Cetirizine on Respiratory Function andImmune Function in Children with Asthma[J].Journal of Medical Information,2022,35(20):103.[doi:10.3969/j.issn.1006-1959.2022.03.024]
[9]汪巧仙.孟鲁司特辅助治疗对肺部感染患者临床疗效、炎性因子及免疫功能的影响[J].医学信息,2023,36(15):132.[doi:10.3969/j.issn.1006-1959.2023.15.027]
　WANG Qiao-xian.Effect of Montelukast Adjuvant Therapy on Clinical Efficacy, Inflammatory Factors and Immune Function in Patients with Pulmonary Infection[J].Journal of Medical Information,2023,36(20):132.[doi:10.3969/j.issn.1006-1959.2023.15.027]

更新日期/Last Update: 1900-01-01